Literature DB >> 9874102

The specificity of antibody in chickens immunised to reduce intestinal colonisation with Campylobacter jejuni.

P R Widders1, L M Thomas, K A Long, M A Tokhi, M Panaccio, E Apos.   

Abstract

Poultry consumption has been identified as a major risk factor for human infection with Campylobacter jejuni in developed countries. C. jejuni is present in the gastrointestinal tract of broiler chickens at the time of slaughter, and faecal contamination of carcases during processing results in significant campylobacter loads on carcases. One approach to reducing the level of carcase contamination with C. jejuni is to control campylobacter infection in broiler chickens. To this end, the study described here investigated the specificity of antibody in serum and intestinal secretions of chickens that had been immunised with campylobacter antigens and then challenged with viable bacteria. The immunodominant antigens in the serum of birds that showed a 2-log reduction in caecal colonisation with C. jejuni included flagellin protein (61-63 Kd) and three additional antigens of 67, 73.5 and 77.5 Kd. Only flagellin and the 67 Kd antigen were recognised by IgG antibody in gastrointestinal secretions of the same birds. Antibody from chickens immunised with purified native flagellin protein recognised flagellin protein and the 67 Kd antigen in Western blots probed with serum, but only the flagellin proteins (61-63 Kd) in Westerns probed with gastrointestinal secretions. Analysis of the specificity of the response to flagellin protein using recombinant clones that expressed regions of the flagellin gene suggests that epitopes in each region of the flagellin protein were immunogenic. Of the immunodominant antigens, only flagellin appeared to be surface-exposed on viable C. jejuni, although conformational epitopes of flagellin appeared to be sensitive to the method of antigen purification. The results of this study suggest that flagellin and possibly the 67 Kd antigen may be valuable for immunological control of intestinal infection with C. jejuni in chickens, but that further work is required to purify these as vaccine candidates by using methods that preserve conformational epitopes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9874102     DOI: 10.1016/s0378-1135(98)00251-x

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  15 in total

Review 1.  Flagellin a toll-like receptor 5 agonist as an adjuvant in chicken vaccines.

Authors:  Shishir Kumar Gupta; Preety Bajwa; Rajib Deb; Madhan Mohan Chellappa; Sohini Dey
Journal:  Clin Vaccine Immunol       Date:  2014-01-22

Review 2.  Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.

Authors:  Miguel O'Ryan; Roberto Vidal; Felipe del Canto; Juan Carlos Salazar; David Montero
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Evaluation of Salmonella-vectored Campylobacter peptide epitopes for reduction of Campylobacter jejuni in broiler chickens.

Authors:  S L Layton; M J Morgan; K Cole; Y M Kwon; D J Donoghue; B M Hargis; N R Pumford
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

4.  Prevalence, antigenic specificity, and bactericidal activity of poultry anti-Campylobacter maternal antibodies.

Authors:  O Sahin; Q Zhang; J C Meitzler; B S Harr; T Y Morishita; R Mohan
Journal:  Appl Environ Microbiol       Date:  2001-09       Impact factor: 4.792

5.  Impact of DNA Prime/Protein Boost Vaccination against Campylobacter jejuni on Immune Responses and Gut Microbiota in Chickens.

Authors:  Noémie Gloanec; Daniel Dory; Ségolène Quesne; Véronique Béven; Typhaine Poezevara; Alassane Keita; Marianne Chemaly; Muriel Guyard-Nicodème
Journal:  Vaccines (Basel)       Date:  2022-06-20

6.  Intranasal immunization with chitosan/pCAGGS-flaA nanoparticles inhibits Campylobacter jejuni in a White Leghorn model.

Authors:  Jin-lin Huang; Yan-Xin Yin; Zhi-ming Pan; Gong Zhang; Ai-ping Zhu; Xiu-fan Liu; Xin-an Jiao
Journal:  J Biomed Biotechnol       Date:  2010-08-16

7.  Serological assessment of synthetic peptides of Campylobacter jejuni NCTC11168 FlaA protein using antibodies against multiple serotypes.

Authors:  Ursla Fernando; Debabrata Biswas; Brenda Allan; Sam Attah-Poku; Philip Willson; Alfonso Valdivieso-Garcia; Andrew A Potter
Journal:  Med Microbiol Immunol       Date:  2007-08-18       Impact factor: 3.402

8.  Campylobacter jejuni is not merely a commensal in commercial broiler chickens and affects bird welfare.

Authors:  Suzanne Humphrey; Gemma Chaloner; Kirsty Kemmett; Nicola Davidson; Nicola Williams; Anja Kipar; Tom Humphrey; Paul Wigley
Journal:  MBio       Date:  2014-07-01       Impact factor: 7.867

9.  Identification of Novel Vaccine Candidates against Campylobacter through Reverse Vaccinology.

Authors:  Marine Meunier; Muriel Guyard-Nicodème; Edouard Hirchaud; Alberto Parra; Marianne Chemaly; Daniel Dory
Journal:  J Immunol Res       Date:  2016-06-16       Impact factor: 4.818

10.  Chicken Immune Response after In Ovo Immunization with Chimeric TLR5 Activating Flagellin of Campylobacter jejuni.

Authors:  Katarzyna A Radomska; Mahdi M Vaezirad; Koen M Verstappen; Marc M S M Wösten; Jaap A Wagenaar; Jos P M van Putten
Journal:  PLoS One       Date:  2016-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.